You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Chemical-Imaging Registration and Multi-modal Analysis

    SBC: INTELLISENSE SYSTEMS INC            Topic: CBD212001

    To address the Chemical and Biological Defense (CBD) agency’s need for a new deep learning (DL)-based threat detection solution that fuses imaging sensors and chemical/biological sensors to detect and locate concealed chemical threats, Intellisense Systems, Inc. (Intellisense) proposes to complete the development of the new Chemical-Imaging Registration and Multi-modal Analysis (CIGMA) solution. ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  2. Multi-Modal Detection of Chemical Threats Using Deep Learning- Phase II

    SBC: NOVATEUR RESEARCH SOLUTIONS LLC            Topic: CBD212001

    This SBIR Phase II project proposes development of deep learning based chemical threat detection and localization framework that exploits multiple sensor data streams including imaging and chemical sensors. The proposed technologies combine deep hypernetworks and reinforcement learning techniques to fuse sensor data streams in an online fashion. The Phase II effort will focus on developing an end- ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  3. Passive Standoff Millimeter Wave Imaging System

    SBC: SYGHT INC            Topic: CBD213002

    Syght will develop a stand-off passive millimeter wave imaging system for detection of weapons or Person-Borne Improvised Explosive Devices (IEDs) concealed under clothing or in bags and for detection of Leave-Behind IEDs through obscurants such as camouflage, dust, and smoke.

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  4. Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial

    SBC: Clear Scientific, LLC            Topic: CBD212004

    Treatment for acute nerve agent poisoning would greatly benefit from the additional use of a scopolamine hydrobromide injectable. However, addition of a single-dose scopolamine injectable to the warfighter kit represents a substantial logistical burden in the field. A multi-dose vial formulation of scopolamine that is effectively antimicrobial and stable in the field would alleviate logistical bur ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  5. Succor Combat Foam for Treatment of Dermal Injuries Caused by Sulfur Mustard

    SBC: CRITICAL INNOVATIONS LLC            Topic: CBD212005

    The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) seeks to develop dermal dressing technologies that provide multiple advantages over current wound dressings for treating dermal injuries caused by sulfur mustard. Critical Innovations, Battelle's Biomedical Research Center, the U.S. Army Combat Capabilities Development Command Chemical Biologic ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  6. Pharmaceutical Development, Planning, and CMO Identification for the Expedited Advancement of a Scopolamine Multi-Dose-Vial Drug Product

    SBC: CMC PHARMACEUTICALS INC            Topic: CBD212004

    CMC Pharma is proposing this Phase II SBIR to continue the development and testing of a multi-dose vial of a scopolamine hydrobromide trihydrate (Scop-HBT) ready-to-use intramuscular solution formulation. The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) is developing Scop-HBT under the Improved Nerve Agent Treatment System - Centrally Acting ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  7. Artificial Intelligence Tool for Chemical and Biological Plumes Detection

    SBC: SPECTRAL SCIENCES INC            Topic: CBD202002

    Accurate and timely detection and classification of chemical and/or biological threat agents (CBA) used by an adversary in a battlefield environment is a crucial task for reconnaissance and force protection systems. A key technology component in CBA plume sensing systems is the light detection and ranging (LIDAR) system. In Phase I a preliminary AI algorithm based on the autoencoding technique was ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  8. Phase Sensitive Millimeter Wave Imaging with Metamaterials

    SBC: SRICO INC            Topic: CBD213002

    SRICO proposes state-of-the-art metamaterial based sensing technology to coherent hyperspectral imaging in the W-band portion of the MMW spectrum. The metamaterial absorber pixel design provides spectrally tailored and phase sensitive vector mode sensing capability critical for W-band imaging. The proposed imaging array features spectrally tailored and deeply sub-wavelength size metamaterial pixel ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  9. HoloWarriorTM Augmented Reality CBRN Threat Display for Mounted Situational Awareness

    SBC: VR REHAB INC            Topic: CBD212002

    VR Rehab, Inc. (VRR) HoloWarrior™:CBRN system’s intuitive AR/MR 3D visualizations enables enhanced CBRN situational awareness for better and faster decision making while also reducing cognitive workload. This CBD/DTRA sponsored Phase-II will quantify the large-scale performance increases and usability optimizations. Benefits are anticipated to align with our similar AR/MR visualizations large- ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
  10. Development of Small Molecule Therapeutics Specifically Targeting Members of the Bunyavirales Order

    SBC: FABRICO TECHNOLOGY, INC.            Topic: CBD212006

    Fabrico Technology, Professor Kevin Dalby, the Johnson & Johnson Centennial Professor of Chemical Biology & Medicinal Chemistry, and Dr. Tamer Kaoud, Research Assistant Professor of Chemical Biology & Medicinal Chemistry, College of Pharmacy, the University of Texas at Austin (UT), have successfully met and exceeded the Phase I technical objectives as specified in the original Phase I solicitation ...

    SBIR Phase II 2023 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government